Skip to main content

Advertisement

SpringerLink
Log in

Treatment of premature ejaculation: new drugs and treatment strategies

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment and the belief that PE is a normal part of aging, has no effective treatment, or will resolve itself, few men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods; desensitizing drugs; off-label use of antidepressants and/or phosphodiesterase type 5 inhibitors or α-blockers), the majority of men with PE generally are not satisfied with their results. New pharmacologic drugs, specifically for the treatment of PE, are undergoing evaluation in clinical trials. As an example, recent clinical research studies have revealed on-demand administration of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development may provide benefits over those available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Carson CC, Glasser DB, Laumann EO, et al.: Prevalence and correlates of premature ejaculation among men aged 40 years and older: A United States nationwide population-based study [Abstract 1249]. J Urol 2003, 169(Suppl 4):321.

    Google Scholar 

  2. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281:537–544.

    Article  PubMed  CAS  Google Scholar 

  3. Rosen R, Porst H, Montorsi F: The premature ejaculation prevalence and attitudes (PEPA) survey: a multi-national survey. J Sex Med 2004, 1(Suppl 1):57–58.

    Google Scholar 

  4. Rowland D, Perelman M, Althof S, et al.: Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004, 1:225–232. This study examined the utility of self-reported answers to questions based on the DSM-IV-TR definition of PE. It also evaluates the relationship between a man’s perception of ejaculatory performance and associated levels of interpersonal distress.

    Article  PubMed  Google Scholar 

  5. Moreira ED, Jr: Help-seeking behaviour for sexual problems: the Global Study of Sexual Attitudes and Behaviors. Int J Clin Pract 2005, 59:6.

    Article  PubMed  Google Scholar 

  6. Symonds T, Roblin D, Hart K, Althof S: How does premature ejaculation impact a man’s life? J Sex Marital Ther 2003, 29:361–370.

    Article  PubMed  CAS  Google Scholar 

  7. Bell AP: Human sexuality--a response. Int J Psychiatry 1972, 10:99–102.

    PubMed  CAS  Google Scholar 

  8. Masters W, Johnson V: Human sexual inadequacy. Boston: Little Brown & Co.; 1970.

    Google Scholar 

  9. Patrick DL, Althof SE, Pryor JL, et al.: Premature ejaculation: an observational study of men and their partners. J Sex Med 2005, 2:358–367. This study discussed and defined PE utilizing patient-reported outcome measures from men and their partners.

    Article  PubMed  Google Scholar 

  10. Rust J, Golombok S, Collier J: Marital problems and sexual dysfunction: how are they related? Br J Psychiatry 1988, 152:629–631.

    PubMed  CAS  Google Scholar 

  11. Waldinger MD: An empirical operationalization study of DSM IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract 1998, 2:287–293.

    Article  Google Scholar 

  12. Montague DK, Jarow J, Broderick G, et al.: AUA Guideline on the Pharmacologic Management of Premature Ejaculation. J Urol 2004, 172:290–294.

    Article  PubMed  Google Scholar 

  13. Truitt WA, Coolen LM: Identification of a potential ejaculation generator in the spinal cord. Science 2002, 297:1566–1569.

    Article  PubMed  CAS  Google Scholar 

  14. Perretti A, Catalano A, Mirone V, et al.: Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. Urology 2003, 61:623–628.

    Article  PubMed  CAS  Google Scholar 

  15. Waldinger MD, Berendsen HH, Blok BF, et al.: Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998, 92:111–118.

    Article  PubMed  CAS  Google Scholar 

  16. Waldinger MD: The neurobiological approach to premature ejaculation. J Urol 2002, 168:2359–2367.

    Article  PubMed  Google Scholar 

  17. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B: Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998, 18:274–281.

    Article  PubMed  CAS  Google Scholar 

  18. Grenier G, Byers ES: Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav 1995, 24:447–472.

    Article  PubMed  CAS  Google Scholar 

  19. St Lawrence JS, Madakasira S: Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatry Med 1992, 22:77–97.

    Article  Google Scholar 

  20. Atmaca M, Kuloglu M, Tezcan E, et al.: Serum leptin levels in patients with premature ejaculation. Arch Androl 2002, 48:345–350.

    Article  PubMed  CAS  Google Scholar 

  21. Shamloul R, Nashaar A: Chronic prostatitis in premature ejaculation: A cohort study in 153 men. J Sex Med 2006, 3:150–154.

    Article  PubMed  Google Scholar 

  22. Wang W, Kumar P, Minhas S, Ralph D: Proposals or findings for a new approach about how to define and diagnose premature ejaculation. Eur Urol 2005, 48:418–423.

    PubMed  Google Scholar 

  23. Safarinejad MR, Hosseini SY: Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 2006, 26:27–31.

    Article  PubMed  CAS  Google Scholar 

  24. Basar M, Yilmaz E, Ferhat M, et al.: Terazosin in the treatment of premature ejaculation: A short-term follow-up. Int Urol Nephrol 2005, 37:773–777.

    Article  PubMed  CAS  Google Scholar 

  25. Optale G, Pastore M, Marin S, et al.: Male sexual dysfunctions: immersive virtual reality and multimedia therapy. Stud Health Technol Inform 2004, 99:165–178.

    PubMed  Google Scholar 

  26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), edn 4. Washington, DC: American Psychiatric Association; 2000.

  27. McMahon CG, Abdo C, Incrocci L, et al.: Disorders of Orgasm and Ejaculation in Men. J Sex Med 2004, 1:58–65. This paper provided recommendations for the management of ejaculatory disorders in men.

    Article  PubMed  Google Scholar 

  28. Jannini EA, Lenzi A: Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol 2005, 23:68–75.

    Article  PubMed  Google Scholar 

  29. Levine SB: Premature ejaculation: some thoughts about its pathogenesis. J Sex Marital Ther 1975, 1:326–334.

    PubMed  CAS  Google Scholar 

  30. Rowland DL, Cooper SE, Schneider M: Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav 2001, 30:235–253.

    Article  PubMed  CAS  Google Scholar 

  31. Waldinger MD, Rietschel M, Nothen MM, et al.: Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998, 37–40.

  32. Grenier G, Byers ES: Operationalizing premature or rapid ejaculation. J Sex Res 2001, 38:369–378.

    Article  Google Scholar 

  33. Rowland DL, Strassberg DS, de Gouveia Brazao CA, Slob AK: Ejaculatory latency and control in men with premature ejaculation: an analysis across sexual activities using multiple sources of information. J Psychosom Res 2000, 48:69–77.

    Article  PubMed  CAS  Google Scholar 

  34. Giuliano F, Niederberger C, Rosen R, et al.: Identification of key criteria for distinguishing between subjects with and without premature ejaculation (PE) in clinical trials [Abstract 47]. Abstract presented at the Fall Meeting of the Sexual Medicine Society of North America. New York, NY; November 17–20, 2005.

  35. Atikeler MK, Gecit I, Senol FA: Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia 2002, 34:356–359.

    Article  PubMed  CAS  Google Scholar 

  36. Busato W, Galindo CC: Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int 2004, 93:1018–1021.

    Article  PubMed  CAS  Google Scholar 

  37. Rosen RC, Lane RM, Menza M: Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999, 19:67–85.

    Article  PubMed  CAS  Google Scholar 

  38. Stone KJ, Viera AJ, Parman CL: Off-label applications for SSRIs. Am Fam Physician 2003, 68:498–504.

    PubMed  Google Scholar 

  39. Waldinger MD, Zwindermann AH, Schweitzer DH, Olivier B: Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004, 16:369–381. This demonstrated that the methodology used in studies to evaluate the efficacy of treatments in PE may influence the outcome measures.

    Article  PubMed  CAS  Google Scholar 

  40. McMahon CG, Touma K: Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 1999, 11:241–245.

    Article  PubMed  CAS  Google Scholar 

  41. Waldinger MD, Hengeveld MW, Zwinderman AH: Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994, 151:1377–1379.

    PubMed  CAS  Google Scholar 

  42. Kilic S, Ergin H, Baydinc YC: Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug. Int J Androl 2005, 28:47–52.

    Article  PubMed  CAS  Google Scholar 

  43. Althof SE, Levine SB, Corty EW, et al.: A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995, 56:402–407.

    PubMed  CAS  Google Scholar 

  44. Haensel SM, Rowland DL, Kallan KT: Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996, 156:1310–1315.

    Article  PubMed  CAS  Google Scholar 

  45. Waldinger MD, Zwinderman AH, Olivier B: On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 2004, 46:510–516.

    PubMed  CAS  Google Scholar 

  46. Kara H, Aydin S, Yucel M, et al.: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol 1996, 156:1631–1632.

    Article  PubMed  CAS  Google Scholar 

  47. McMahon CG: Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998, 159:1935–1938.

    Article  PubMed  CAS  Google Scholar 

  48. McMahon CG, Samali R: Pharmacological treatment of premature ejaculation. Curr Opin Urol 1999, 9:553–561.

    Article  PubMed  CAS  Google Scholar 

  49. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, et al.:SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997, 23:176–194.

    PubMed  CAS  Google Scholar 

  50. Waldinger MD, Quinn P, Dilleen M, et al.: A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005, 2:492–497. This study was the first to assess the IELT distribution in the general male population from five countries.

    Article  PubMed  Google Scholar 

  51. Abdel-Hamid IA, El Naggar EA, El Gilany AH: Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001, 13:41–45.

    Article  PubMed  CAS  Google Scholar 

  52. Salonia A, Maga T, Colombo R, et al.: A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002, 168:2486–2489.

    Article  PubMed  CAS  Google Scholar 

  53. Mondaini N, Ponchietti R, Muir GH, et al.: Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res 2003, 15:225–228. Sildenafil did not improve erectile quality in healthy young men without ED.

    Article  PubMed  CAS  Google Scholar 

  54. Chia S: Management of premature ejaculation--a comparison of treatment outcome in patients with and without erectile dysfunction. Int J Androl 2002, 25:301–305.

    Article  PubMed  Google Scholar 

  55. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A: Efficacy of Sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003, 61:197–200.

    Article  PubMed  Google Scholar 

  56. Pryor JL, Althof SE, Steidle C, et al.: Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomized controlled trials. Lancet 2006 368:939–947. This study demonstrated that dapoxetine, 30 mg and 60 mg doses effectively increased IELT, improved control over ejaculation, and increased satisfaction with sexual intercourse following ondemand administration.

    Google Scholar 

  57. Modi NB, Dresser MJ, Simon M, et al.: Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol 2006, 46:301–309.

    Article  PubMed  CAS  Google Scholar 

  58. Althof SE: Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome. World J Urol 2005, 23:89–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Tulane University Medical Center, 1430 Tulane Avenue, 701120-2632, New Orleans, LA, USA

    Wayne J. G. Hellstrom MD, FACS

Authors
  1. Wayne J. G. Hellstrom MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jay W. Heintz MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wayne J. G. Hellstrom MD, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hellstrom, W.J.G., Heintz, J.W. Treatment of premature ejaculation: new drugs and treatment strategies. Curr Urol Rep 7, 473–478 (2006). https://doi.org/10.1007/s11934-006-0057-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-006-0057-2

Keywords

Search

Navigation